Clinical trials
Herpes Genitalis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
69 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 4 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 8 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Terminated | 8 |
| Unknown status | 7 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Washington | 8 |
| GlaxoSmithKline | 7 |
| Glaxo Wellcome | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 4 |
| Novartis | 4 |
| French National Agency for Research on AIDS and Viral Hepatitis | 3 |
| Genocea Biosciences, Inc. | 3 |
| Agenus Inc. | 2 |
| Assembly Biosciences | 2 |
| Roxane Laboratories | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Herpes Genitalis | 69 |
| Herpes Simplex | 17 |
| HIV Infections | 15 |
| Acquired Immunodeficiency Syndrome | 4 |
| Sexually Transmitted Diseases | 4 |
| Anus Diseases | 3 |
| Herpes Zoster | 3 |
| Recurrence | 3 |
| AIDS-Related Complex | 2 |
| Chlamydia Infections | 2 |
Trials
Showing 51 to 69 of 69. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.